Clinical Trial Update: A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea [Phase 3]

View source ↗

Summary

Phase 3 trial comparing two topical metronidazole gel 1% treatments for rosacea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythematotelangiectatic Rosacea
• Papulopustular Rosacea

Drugs mentioned

• Metronidazole gel 1% (metronidazole)

Snippet

Sponsor: bioRASI, LLC | Conditions: Papulopustular Rosacea, Erythematotelangiectatic Rosacea | Phase 3 | Status: COMPLETED